Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lonafarnib

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Lonafarnib?

Lonafarnib is an investigational drug.

There have been 31 clinical trials for Lonafarnib. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2002.

The most common disease conditions in clinical trials are Hepatitis D, Hepatitis, and Hepatitis D, Chronic. The leading clinical trial sponsors are Schering-Plough, National Cancer Institute (NCI), and Eiger BioPharmaceuticals.

Recent Clinical Trials for Lonafarnib
A Phase 3 Study of the Efficacy and Safety of Lonafarnib 50 mg / Ritonavir 100 mg With and Without Pegylated Interferon -Alfa-2a 180 mcg for 48 WeeksEiger BioPharmaceuticalsPhase 3
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
A Study of Lonafarnib With or Without Ritonavir in Patients With HDVEiger BioPharmaceuticalsPhase 2

See all Lonafarnib clinical trials

Clinical Trial Summary for Lonafarnib

Top disease conditions for Lonafarnib
Top clinical trial sponsors for Lonafarnib

See all Lonafarnib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.